ADMA Biologics, Inc. (ADMA)
17.31
-0.19
(-1.09%)
USD |
NASDAQ |
Jan 16, 16:00
17.40
+0.09
(+0.52%)
After-Hours: 20:00
ADMA Biologics Profit Margin (Quarterly): 27.14% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 7.47% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| Aldeyra Therapeutics, Inc. | -- |
| Marker Therapeutics, Inc. | -162.1% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 58.71% |
| Return on Assets | 41.45% |
| Return on Invested Capital | 47.04% |
| Gross Profit Margin (Quarterly) | 56.31% |
| Operating Margin (Quarterly) | 38.01% |
| Return on Net Operating Assets | 61.34% |